Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide on Abdominal Fat in T2D
NCT00701935Phase 2Terminated
- Sponsor
- AstraZeneca
- Start
- Aug 2008
- Primary completion
- Jan 2012
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Aug 2008; status: terminated.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00701935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00701935.